Long-Term Survival After Initial Invasive or Conservative Management of Stable Coronary Disease in ISCHEMIA-EXTEND

医学 射血分数 血运重建 内科学 保守管理 心脏病学 冠状动脉疾病 累积发病率 随机对照试验 药物治疗 临床终点 经皮冠状动脉介入治疗 管理策略 心力衰竭 入射(几何) 比例危险模型 死亡率 冠心病 自然史 存活率 生存分析 心肌梗塞 外科 冠状动脉造影 冲程(发动机) 介入心脏病学 保守治疗 动脉
作者
Judith S. Hochman,Rebecca Anthopolos,Harmony R. Reynolds,Sripal Bangalore,Yifan Xu,Sean M. O’Brien,Stephanie Boumakis,Michelle Chang,Yves Rosenberg,Roxy Senior,Ann Banfield,Shaun G. Goodman,Renato D. Lopes,Radosław Pracoń,Jose Luis Lopez-Sendon,Philippe Gabríel Steg,Aldo Pietro Maggioni,Jonathan D. Newman,Jeffrey S. Berger,Mandeep S. Sidhu
出处
期刊:JAMA [American Medical Association]
标识
DOI:10.1001/jama.2026.20375
摘要

Importance: It is unknown whether routine invasive management of chronic coronary disease improves long-term survival when added to guideline-directed medical therapy. Objective: To compare the effects of initial invasive and conservative strategies on long-term mortality in patients with chronic coronary disease. Design, Setting, and Participants: In this long-term follow-up study of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA), an international trial of patients with chronic coronary disease, moderate or severe ischemia, left ventricular ejection fraction of 35% or more, and no left main coronary artery disease, unacceptable angina, or recent acute coronary syndrome, participants were randomized at 320 sites in 37 countries beginning August 2012 and followed up through December 2025. Data were analyzed using the intention-to-treat principle. Intervention: ISCHEMIA randomized patients to an initial invasive strategy of guideline-directed medical therapy plus coronary angiography and revascularization (when feasible) or an initial conservative strategy with guideline-directed medical therapy alone, with invasive management for failure of medical therapy. Main Outcomes and Measures: All-cause, cardiovascular, and noncardiovascular mortality were analyzed using cumulative incidence estimates, Cox and Fine-Gray models, bayesian analysis, and restricted mean survival time. Results: Among 5179 participants, median age was 64 (IQR, 58-70) years; 23% were female, 42% had diabetes, and median ejection fraction was 60% (IQR, 55%-65%). During 9-year median follow-up (range, 1 day to 13.4 years), 1071 deaths occurred (782 during extended follow-up): 672 cardiovascular, 359 noncardiovascular, and 40 unclassified. All-cause 11-year mortality was not significantly different between groups (25.8% invasive vs 26.9% conservative; estimated difference, -1.0 percentage point [95% CI, -4.2 to 2.1 percentage points]; adjusted hazard ratio [AHR], 0.97 [95% CI, 0.86-1.09]). By bayesian analysis, the posterior probability of more than 1 percentage-point survival benefit to invasive vs conservative was low (18%). Cardiovascular mortality at 11 years was 15.8% in the invasive group vs 17.1% in the conservative group (estimated difference, -1.4 percentage points [95% CI, -4.0 to 1.3 percentage points]; AHR, 0.88 [95% CI, 0.75-1.02]). Noncardiovascular mortality at 11 years was 9.1% in the invasive group vs 8.1% in the conservative group (estimated difference, 1.0 percentage point [95% CI, -0.9 to 2.9 percentage points]; AHR, 1.18 [95% CI, 0.96-1.45]). Eleven-year restricted mean survival was not significantly different (estimated difference, 14 days [95% CI, -41 to 70 days]). Conclusions and Relevance: In this study, long-term all-cause mortality in patients with high-risk chronic coronary disease was not significantly different after routine invasive vs initial conservative management. Trial Registration: ClinicalTrials.gov Identifier: NCT04894877.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Rea完成签到,获得积分10
刚刚
岁末完成签到 ,获得积分20
1秒前
jeff发布了新的文献求助10
1秒前
吉吉完成签到 ,获得积分10
1秒前
甜甜发布了新的文献求助10
1秒前
完美访烟完成签到,获得积分10
1秒前
2秒前
秋风的应助被张博采纳,获得10
2秒前
2秒前
2秒前
遇见完成签到,获得积分10
2秒前
大意的忆寒完成签到,获得积分10
2秒前
2秒前
04d的应助被gaoyiqing采纳,获得10
3秒前
妍宝贝完成签到 ,获得积分10
3秒前
端庄南莲完成签到,获得积分10
3秒前
现代的雯完成签到,获得积分10
3秒前
3秒前
吹梦西洲发布了新的文献求助10
3秒前
4秒前
DR_XU发布了新的文献求助10
4秒前
爆米花的应助被蒲公英采纳,获得10
4秒前
4秒前
cc完成签到,获得积分10
4秒前
金澜完成签到 ,获得积分10
5秒前
dzh发布了新的文献求助10
5秒前
学术小白two完成签到,获得积分10
5秒前
FashionBoy的应助被huhuiya采纳,获得10
6秒前
Akim的应助被拼搏的似狮采纳,获得10
6秒前
6秒前
erichohos发布了新的文献求助10
6秒前
aaa完成签到,获得积分10
6秒前
Tony发布了新的文献求助10
6秒前
7秒前
鹤这暴脾气完成签到,获得积分10
7秒前
369ninja发布了新的文献求助10
7秒前
mmy完成签到,获得积分20
7秒前
建成发布了新的文献求助30
8秒前
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180531
求助须知:如何正确求助?哪些是违规求助? 9570507
关于积分的说明 21812974
捐赠科研通 7776619
什么是DOI,文献DOI怎么找? 3433286
关于科研通互助平台的介绍 2557539
邀请新用户注册赠送积分活动 2479185